177 related articles for article (PubMed ID: 2651175)
1. Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents.
Apollonio A; Castignani P; Magrini L; Angeletti R
J Int Med Res; 1989; 17(1):28-35. PubMed ID: 2651175
[TBL] [Abstract][Full Text] [Related]
2. [Primary and secondary prevention of ischemic cerebrovascular accidents of arteriosclerosis by platelet inhibitors].
Rosa A; Canaple S
Arch Mal Coeur Vaiss; 1996 Nov; 89(11 Suppl):1563-8. PubMed ID: 9092419
[TBL] [Abstract][Full Text] [Related]
3. Warfarin versus dipyridamole-aspirin and pentoxifylline-aspirin for the prevention of prosthetic heart valve thromboembolism: a prospective randomized clinical trial.
Mok CK; Boey J; Wang R; Chan TK; Cheung KL; Lee PK; Chow J; Ng RP; Tse TF
Circulation; 1985 Nov; 72(5):1059-63. PubMed ID: 3899404
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease.
Trübestein G; Trübestein R; Duong QD
Angiology; 1981 Oct; 32(10):705-10. PubMed ID: 7034591
[TBL] [Abstract][Full Text] [Related]
5. Oral antiplatelet therapy in cerebrovascular disease, coronary artery disease, and peripheral arterial disease.
Tran H; Anand SS
JAMA; 2004 Oct; 292(15):1867-74. PubMed ID: 15494585
[TBL] [Abstract][Full Text] [Related]
6. [Randomized clinical study of the efficacy of buflomedil in the prevention of recurrence of cerebral ischemia in comparison with anti-platelet aggregation agents].
De Martiis M; Parenzi A; Barlattani A; De Martiis A
Clin Ter; 1986 Mar; 116(5):367-71. PubMed ID: 3519061
[No Abstract] [Full Text] [Related]
7. Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants.
Herskovits E; Famulari A; Tamaroff L; Gonzalez AM; Vázquez A; Dominguez R; Fraiman H; Vila J
Eur Neurol; 1985; 24(1):73-81. PubMed ID: 3881263
[TBL] [Abstract][Full Text] [Related]
8. [Ticlopidine and pentoxifylline in acute cerebral infarct. Clinical study on 151 patients].
Zorzon M; Monti F; Del Pio Luogo T; Cazzato G
G Clin Med; 1987 Nov; 68(11):569-72. PubMed ID: 3447921
[No Abstract] [Full Text] [Related]
9. Comparative evaluation of pentoxifylline, buflomedil, and nifedipine in the treatment of intermittent claudication of the lower limbs.
Chacón-Quevedo A; Eguaras MG; Calleja F; Garcia MA; Roman M; Casares J; Muñoz I; Concha M
Angiology; 1994 Jul; 45(7):647-53. PubMed ID: 8024164
[TBL] [Abstract][Full Text] [Related]
10. A randomized clinical trial of pentoxifylline and antiaggregants in recent transient ischemic attacks (TIA). A one year follow-up.
Herskovits E; Vazquez A; Famulari A; Tamaroff L; Fraiman H; Gonzáles AM; Smud R; Vila J; Matera V
Ric Clin Lab; 1981; 11 Suppl 1():257-64. PubMed ID: 6765140
[TBL] [Abstract][Full Text] [Related]
11. Livedo vasculitis. Therapy with pentoxifylline.
Sams WM
Arch Dermatol; 1988 May; 124(5):684-7. PubMed ID: 3364993
[TBL] [Abstract][Full Text] [Related]
12. Impact of pentoxifylline on platelet function profiles in patients with type 2 diabetes mellitus and coronary artery disease on dual antiplatelet therapy with aspirin and clopidogrel.
Ueno M; Ferreiro JL; Tomasello SD; Tello-Montoliu A; Capodanno D; Seecheran N; Kodali M; Dharmashankar K; Desai B; Charlton RK; Bass TA; Angiolillo DJ
JACC Cardiovasc Interv; 2011 Aug; 4(8):905-12. PubMed ID: 21851906
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of and stroke-preventive strategies for atherothromboembolic brain infarction in the elderly.
Adams HP; Gordon DL
Clin Geriatr Med; 1991 Aug; 7(3):401-16. PubMed ID: 1868399
[TBL] [Abstract][Full Text] [Related]
14. Randomised trial of pentoxifylline versus acetylsalicylic acid plus dipyridamole in preventing transient ischaemic attacks.
Herskovits E; Vazquez A; Famulari A; Smud R; Tamaroff L; Fraiman H; Gonzalez AM; Vila J; Matera V
Lancet; 1981 May; 1(8227):966-8. PubMed ID: 6112386
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of chronic obliterative arteriopathy of the legs in the second Fontaine's stage. Personal experience with a buflomedil-pentoxifylline-defibrotide combination].
Marci M; Albiani B; Ricci M; Russo F
Clin Ter; 1995 Mar; 146(3):211-4. PubMed ID: 7789083
[TBL] [Abstract][Full Text] [Related]
16. Antiplatelet therapy for secondary stroke prevention.
Forbes CD
Scott Med J; 1999 Apr; 44(2):54-9. PubMed ID: 10370984
[TBL] [Abstract][Full Text] [Related]
17. The treatment of chronic cerebrovascular insufficiency. A double-blind study with pentoxifylline ('Trental' 400).
Harwart D
Curr Med Res Opin; 1979; 6(2):73-84. PubMed ID: 380914
[No Abstract] [Full Text] [Related]
18. Prevention of post-operative thrombosis in peripheral arteriopathies. Pentoxifylline vs. conventional antiaggregants: a six-month randomized follow-up study.
Lucas MA
Angiology; 1984 Jul; 35(7):443-50. PubMed ID: 6465619
[TBL] [Abstract][Full Text] [Related]
19. A controlled study on the effect of pentoxifylline and an ergot alkaloid derivative on regional cerebral blood flow in patients with chronic cerebrovascular disease.
Hartmann A; Tsuda Y
Angiology; 1988 May; 39(5):449-57. PubMed ID: 3288016
[TBL] [Abstract][Full Text] [Related]
20. [Controlled cooperative trial of secondary prevention of cerebral ischemic accidents caused by atherosclerosis, using aspirin and dipyridamole].
Bousser MG; Eschwège E; Haguenau M; Lefauconnier JM; Thibult N; Touboul D; Touboul PJ
Presse Med; 1983 Dec; 12(48):3049-57. PubMed ID: 6228913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
